A Randomized, Non-Blinded Clinical Trial of a Non-Invasive Perfusion Enhancement System (Guardian System) on Motor Recovery and Impact on Length ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2018-2019

ABSTRACT

This is a non-blinded randomized study that will investigate whether the use of a novel, non-invasive perfusion enhancement system (The Guardian System) impacts motor recovery and hospital length of stay in acute ischemic stroke patients. Detailed Description This clinical research study is a prospective, non-blinded randomized clinical trial. The study protocol and consent form have been approved by the IRB at the Study Institution. As per the study design, consecutive adult patients admitted to the neuro-intensive care unit, with acute ischemic stroke, meeting the inclusion and exclusion criteria will be consented and enrolled in the study. Both the Study and Control groups will receive the standard of care for ischemic stroke according to the hospitals' protocols, policies and procedures. After obtaining informed consent, patients in the study arm will have the non-invasive perfusion enhancement system (The Guardian System) placed on their beds and chairs. The inflatable surfaces (the enhancers) will be placed directly on the mattress and chair under the fitted sheet and bed linens. They will be secured with a non-porous, non-slip silicone attacher. An adaptive pressure controller will be attached to the perfusion enhancer through a connector set. The adaptive pressure controller will be secured to the bed foot board or side rail and have the ability to be secured to an Intravenous pole as necessary. Specific data points for each patient in the Experimental group will be entered into the Controller: they include the patient's weight in kilograms and the patient's position (bed or chair). This study seeks to evaluate the device's effect on motor recovery and length of stay in a homogeneous ischemic stroke population that will be randomized for use of the novel non-invasive perfusion enhancement device from admission to discharge. More... »

URL

https://clinicaltrials.gov/show/NCT03673241

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This is a non-blinded randomized study that will investigate whether the use of a novel, non-invasive perfusion enhancement system (The Guardian System) impacts motor recovery and hospital length of stay in acute ischemic stroke patients.\n\nDetailed Description\nThis clinical research study is a prospective, non-blinded randomized clinical trial. The study protocol and consent form have been approved by the IRB at the Study Institution. As per the study design, consecutive adult patients admitted to the neuro-intensive care unit, with acute ischemic stroke, meeting the inclusion and exclusion criteria will be consented and enrolled in the study. Both the Study and Control groups will receive the standard of care for ischemic stroke according to the hospitals' protocols, policies and procedures. After obtaining informed consent, patients in the study arm will have the non-invasive perfusion enhancement system (The Guardian System) placed on their beds and chairs. The inflatable surfaces (the enhancers) will be placed directly on the mattress and chair under the fitted sheet and bed linens. They will be secured with a non-porous, non-slip silicone attacher. An adaptive pressure controller will be attached to the perfusion enhancer through a connector set. The adaptive pressure controller will be secured to the bed foot board or side rail and have the ability to be secured to an Intravenous pole as necessary. Specific data points for each patient in the Experimental group will be entered into the Controller: they include the patient's weight in kilograms and the patient's position (bed or chair). This study seeks to evaluate the device's effect on motor recovery and length of stay in a homogeneous ischemic stroke population that will be randomized for use of the novel non-invasive perfusion enhancement device from admission to discharge.", 
    "endDate": "2019-03-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03673241", 
    "keywords": [
      "clinical trial", 
      "enhancement", 
      "guardian", 
      "motor recovery", 
      "mobility", 
      "ischemic stroke patient", 
      "randomized study", 
      "hospital length", 
      "acute ischemic stroke patient", 
      "clinical research study", 
      "randomized clinical trial", 
      "study protocol", 
      "consent form", 
      "institution", 
      "study design", 
      "adult patient", 
      "intensive care unit", 
      "acute ischemic stroke", 
      "inclusion", 
      "exclusion criterion", 
      "control", 
      "care", 
      "ischemic stroke", 
      "hospital", 
      "policy", 
      "method", 
      "informed consent", 
      "patient", 
      "study arm", 
      "bed", 
      "surface", 
      "enhancer", 
      "mattress", 
      "chair", 
      "sheet", 
      "silicone", 
      "controller", 
      "perfusion", 
      "connector", 
      "board", 
      "side", 
      "pole", 
      "specific data", 
      "experimental group", 
      "weight", 
      "Equipment and Supply", 
      "admission", 
      "discharge"
    ], 
    "name": "A Randomized, Non-Blinded Clinical Trial of a Non-Invasive Perfusion Enhancement System (Guardian System) on Motor Recovery and Impact on Length of Stay in Mobility Impaired Ischemic Stroke Patients", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03673241"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00028.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.413165.4", 
        "type": "Organization"
      }
    ], 
    "startDate": "2018-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1155/2014/261697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003827667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007707060", 
          "https://doi.org/10.1038/nm.2507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-7-97", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017565580", 
          "https://doi.org/10.1186/1479-5876-7-97"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000353125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026288390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/00004647-199901000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028493892", 
          "https://doi.org/10.1097/00004647-199901000-00010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1179/016164104x2357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029209407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14336/ad.2014.0500294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067267928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078354400", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/won.0000000000000450", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104502950"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03673241"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03673241'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03673241'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03673241'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03673241'


 

This table displays all metadata directly associated to this object as RDF triples.

96 TRIPLES      16 PREDICATES      72 URIs      57 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03673241 schema:about anzsrc-for:3120
2 schema:description This is a non-blinded randomized study that will investigate whether the use of a novel, non-invasive perfusion enhancement system (The Guardian System) impacts motor recovery and hospital length of stay in acute ischemic stroke patients. Detailed Description This clinical research study is a prospective, non-blinded randomized clinical trial. The study protocol and consent form have been approved by the IRB at the Study Institution. As per the study design, consecutive adult patients admitted to the neuro-intensive care unit, with acute ischemic stroke, meeting the inclusion and exclusion criteria will be consented and enrolled in the study. Both the Study and Control groups will receive the standard of care for ischemic stroke according to the hospitals' protocols, policies and procedures. After obtaining informed consent, patients in the study arm will have the non-invasive perfusion enhancement system (The Guardian System) placed on their beds and chairs. The inflatable surfaces (the enhancers) will be placed directly on the mattress and chair under the fitted sheet and bed linens. They will be secured with a non-porous, non-slip silicone attacher. An adaptive pressure controller will be attached to the perfusion enhancer through a connector set. The adaptive pressure controller will be secured to the bed foot board or side rail and have the ability to be secured to an Intravenous pole as necessary. Specific data points for each patient in the Experimental group will be entered into the Controller: they include the patient's weight in kilograms and the patient's position (bed or chair). This study seeks to evaluate the device's effect on motor recovery and length of stay in a homogeneous ischemic stroke population that will be randomized for use of the novel non-invasive perfusion enhancement device from admission to discharge.
3 schema:endDate 2019-03-01T00:00:00Z
4 schema:keywords Equipment and Supply
5 acute ischemic stroke
6 acute ischemic stroke patient
7 admission
8 adult patient
9 bed
10 board
11 care
12 chair
13 clinical research study
14 clinical trial
15 connector
16 consent form
17 control
18 controller
19 discharge
20 enhancement
21 enhancer
22 exclusion criterion
23 experimental group
24 guardian
25 hospital
26 hospital length
27 inclusion
28 informed consent
29 institution
30 intensive care unit
31 ischemic stroke
32 ischemic stroke patient
33 mattress
34 method
35 mobility
36 motor recovery
37 patient
38 perfusion
39 pole
40 policy
41 randomized clinical trial
42 randomized study
43 sheet
44 side
45 silicone
46 specific data
47 study arm
48 study design
49 study protocol
50 surface
51 weight
52 schema:name A Randomized, Non-Blinded Clinical Trial of a Non-Invasive Perfusion Enhancement System (Guardian System) on Motor Recovery and Impact on Length of Stay in Mobility Impaired Ischemic Stroke Patients
53 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03673241
54 schema:sdDatePublished 2019-03-07T15:28
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N5ad302de291f4d9597182688fa45ad5d
57 schema:sponsor https://www.grid.ac/institutes/grid.413165.4
58 schema:startDate 2018-10-01T00:00:00Z
59 schema:subjectOf sg:pub.10.1038/nm.2507
60 sg:pub.10.1097/00004647-199901000-00010
61 sg:pub.10.1186/1479-5876-7-97
62 https://app.dimensions.ai/details/publication/pub.1078354400
63 https://doi.org/10.1097/won.0000000000000450
64 https://doi.org/10.1155/2014/261697
65 https://doi.org/10.1159/000353125
66 https://doi.org/10.1179/016164104x2357
67 https://doi.org/10.14336/ad.2014.0500294
68 schema:url https://clinicaltrials.gov/show/NCT03673241
69 sgo:license sg:explorer/license/
70 sgo:sdDataset clinical_trials
71 rdf:type schema:MedicalStudy
72 N5ad302de291f4d9597182688fa45ad5d schema:name Springer Nature - SN SciGraph project
73 rdf:type schema:Organization
74 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
75 rdf:type schema:DefinedTerm
76 sg:pub.10.1038/nm.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007707060
77 https://doi.org/10.1038/nm.2507
78 rdf:type schema:CreativeWork
79 sg:pub.10.1097/00004647-199901000-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028493892
80 https://doi.org/10.1097/00004647-199901000-00010
81 rdf:type schema:CreativeWork
82 sg:pub.10.1186/1479-5876-7-97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017565580
83 https://doi.org/10.1186/1479-5876-7-97
84 rdf:type schema:CreativeWork
85 https://app.dimensions.ai/details/publication/pub.1078354400 schema:CreativeWork
86 https://doi.org/10.1097/won.0000000000000450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104502950
87 rdf:type schema:CreativeWork
88 https://doi.org/10.1155/2014/261697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003827667
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1159/000353125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026288390
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1179/016164104x2357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029209407
93 rdf:type schema:CreativeWork
94 https://doi.org/10.14336/ad.2014.0500294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067267928
95 rdf:type schema:CreativeWork
96 https://www.grid.ac/institutes/grid.413165.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...